The Huashan Hospital team conducts the first clinical trial of BCI products at Neuracle Medical Technology (Shanghai) Co Ltd. [Photo provided to chinadaily.com.cn] Following its market approval in ... ( read original story ...)
Shanghai hospital completes China’s first commercial BCI surgery
A Shanghai hospital has performed China's first commercial brain-computer interface (BCI) surgery following the market approval of a domestically developed implantable system designed to compensate ... ( read original story ...)
DeepSeek eyes Shanghai IPO next year – report
DeepSeek is eyeing an initial public offering in Shanghai as early as the second quarter of next year, The Wall Street Journal reported, citing people familiar with the matter. Ch ... ( read original story ...)
Eyeing valuation jump, investors prep bids for chip giant CXMT’s $8.6 billion IPO
By Summer Zhen and Samuel Shen HONG KONG, July 15 (Reuters) - Chinese investors seeking shares in CXMT's $8.6 billion IPO are betting the Chinese chipmaker's valuation will soar as much as 10-fold ... ( read original story ...)
China memory giant CXMT valued at US$85 billion in record Shanghai IPO
Chinese DRAM maker is set to raise 57.9 billion yuan (US$8.5 billion), nearly twice the amount earmarked for its investment projects China's leading memory chipmaker, ChangXin Memory Technologies ... ( read original story ...)
Chinese memory giant CXMT seeks US$9.8 bil in marquee IPO
China’s drive for semiconductor self-sufficiency is reaching a milestone as memory chipmaker CXMT Corp launches a near-record initial public offering. ( read original story ...)
ChangXin hopes to raise $8.5B in IPO as it takes advantage of global memory crunch: report
China's most prolific producer of high-bandwidth memory, plans to raise $8.5B in its initial public offering on the Shanghai Stock Exchange, which is slated for July 27, according to Reuters. HBM is a ... ( read original story ...)